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Summary
 
Lineage commitment in B lymphopoiesis remains poorly understood due to the inability to
clearly define newly committed B lineage progenitors and their multipotential descendants. We
examined the potential of three recently described progenitor populations in adult mouse bone
marrow to differentiate into each hematopoietic lineage. The earliest of these, termed fraction
 
(Fr.) A
 
0
 
, exhibited myeloid, erythroid, and B and T lymphoid progenitor activity and included
individual cells with myeloid/B lymphoid potential. In sharp contrast, two later populations,
termed Frs. A
 
1
 
 and A
 
2
 
 and characterized by surface B220 expression and transcription of the
germline immunoglobulin heavy chain (IgH) locus, lacked progenitor activity for all hemato-
poietic lineages except B lymphocytes. These observations, together with single cell poly-
merase chain reaction analysis showing a lack of D
 
H
 
J
 
H 
 
rearrangements in each population and
experiments showing identical precursor potentials when these populations were derived from
 
recombination activating gene (Rag)-1
 
2
 
/
 
2
 
 and J
 
H
 
2
 
/
 
2
 
 mice, demonstrate that commitment to
the B lymphoid lineage occurs before and independently of V
 
H
 
D
 
H
 
J
 
H
 
 recombination.
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I
 
n adult mice, B lymphocytes ultimately arise from pluri-
potent stem cells in the bone marrow (BM). Current
models predict that the differentiation of multipotential
BM progenitor cells into B lineage–committed precursors,
incapable of giving rise to alternative hematopoietic lin-
eages, requires the stage-specific activity of key gene prod-
ucts (1). However, despite intensive interest in early B cell
development, elucidation of the molecular mechanisms un-
derlying B lineage commitment has been hampered by the
inability to clearly define the earliest B lineage–restricted
progenitor cells and their immediate unrestricted precur-
sors.
A large body of work has been devoted to defining mul-
tipotent hematopoietic progenitor populations. Pluripotent
stem cells have been identified in BM (2) and fetal liver (3,
4), bipotential myeloid/B lymphoid progenitors have been
identified in fetal liver (5), and lymphoid-restricted progen-
itors have been identified in adult thymus (6) and BM (7).
Recently we described three novel cell populations in adult
BM, termed fractions (Frs.) A
 
0
 
, A
 
1
 
, and A
 
2
 
 (8). Among
these, Frs. A
 
1
 
 and A
 
2
 
 exhibit numerous characteristics con-
sistent with their designation as precursors for pro-B cells
or pre–pro-B cells (9). Thus, whereas expression of 
 
l
 
5 and
recombination activating gene (Rag)-1/2 is restricted to Fr.
A
 
2
 
 and more mature subsets, Frs. A
 
1
 
 and A
 
2
 
 each exhibit
surface B220 expression, express transcripts for the germ-
line IgH locus (
 
m
 
0
 
), and proliferate in short-term stromal
cultures supplemented with IL-7 (8).
The developmental potential of pre–pro-B cells and the
role V
 
H
 
D
 
H
 
J
 
H
 
 recombination plays in the restriction of mul-
tipotential progenitor cells to the B lymphoid lineage have
not been explored. Although cells containing IgH recom-
bination events are often referred to as B lineage commit-
ted, the existence of natural and induced myelogenous tu-
mor cells containing IgH rearrangements suggests that B
lineage commitment can occur after such events (10–13).
However, here we report that whereas the precursors of
pre–pro-B cells in Fr. A
 
0
 
 exhibit progenitor activity for
multiple hematopoietic lineages, pre–pro-B cells in Frs. A
 
1
 
and A
 
2
 
 are B lineage restricted but lack D
 
H
 
J
 
H
 
 rearrange-
ments. This finding demonstrates that B lineage commit-
ment occurs very early in B cell development, before 
 
l
 
5
expression and initiation of D
 
H
 
J
 
H
 
 recombination and coin-
cident with 
 
m
 
0
 
 and surface B220 expression. Furthermore,
identical results were obtained with the equivalent cell
populations from mice incapable of initiating V
 
H
 
D
 
H
 
J
 
H
 
 re-
combination, indicating that mechanisms controlling the
differentiation of multipotential progenitors into B lineage–
committed cells function independently of V
 
H
 
D
 
H
 
J
 
H
 
 recom-
bination. 
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Materials and Methods
 
Preparation of BM Cell Suspensions from Mice.
 
2–4-mo-old fe-
male BALB/c and C57BL/6 mice were obtained from the Insti-
tute for Cancer Research Laboratory Animal Facility. Female
B6.Ly5.2 congenics were obtained from the National Cancer In-
stitute animal facility in Frederick, MD. Rag-1
 
2
 
/
 
2
 
 and J
 
H
 
2
 
/
 
2
 
mice are maintained in our breeding colony. BM cell suspensions
were made as described previously (9).
 
Flow Cytometric Analysis and Cell Sorting.
 
Four-color FACS
 
®
 
analysis and cell sorting of each B lineage cell population were
described previously (8, 9, 14). Five-color FACS
 
®
 
 analyses were
performed by staining adult BM cells with Oregon Green (OG)-
coupled anti-CD4 (GK1.5), biotin anti-B220 (RA3-6B2), allo-
phycocyanin (APC) anti-AA4.1, and PE-Cy5 anti–heat-stable
antigen (anti-HSA) (30F1). PE-coupled antibodies were anti–
Sca-1, anti–IL-7R
 
a
 
 (A7R34), anti-CD3 (500-A2), anti-CD11b
(Mac-1), anti–GR-1 (8C5), anti-CD19 (1D3), and anti-NK1.1
(PK136). APC anti-CD117 (c-kit, clone 2B8) was used in con-
junction with OG–anti-CD4, PE anti-AA4.1, PE-Cy5 anti-
HSA, and biotin anti-B220. Biotinylated antibodies were re-
vealed with Texas Red Avidin, and HSA
 
1
 
 propidium iodide
(PI)
 
1
 
 cells were excluded during data collection. Reagents were
prepared in our laboratory except for FL anti-Ly5.1 (104) and
APC anti–c-kit (2B8), which were purchased from PharMingen.
 
Stromal Cell Cultures.
 
Bulk cultures were established by sort-
ing 10
 
4
 
 cells onto S17 (5) stromal cells in 24-well flat-bottomed
plates as described (9). Numbers of B220
 
1
 
 HSA
 
int
 
 and CD11b
 
1
 
HSA
 
int
 
 cells were determined 4 or 8 d later by flow cytometry.
Limiting dilution cultures were established by sorting 1–100 cells
per well with an automated cell deposition unit directly into 96-
well plates with preestablished S17 stromal cells in standard me-
dium and 100 U/ml rIL-7. Wells containing cell growth were
scored 14 d later, and the presence of B and myeloid lineage cells
was assessed by staining cells with APC-B220, PE-CD11b, and
FL-HSA.
 
Methylcellulose Cultures.
 
Methylcellulose medium containing
IL-3, IL-6, stem cell factor (SCF), and erythropoietin was pur-
chased from Stem Cell Technologies. Triplicate cultures were es-
tablished by plating sorted cells according to the manufacturer’s
instructions. Each culture was scored for the number of granulo-
cytic/macrophage (CFU-GM), erythroid (CFU-BFE), and mixed
(CFU-GEMM) colonies 12 d later.
 
Reverse Transcription PCR.
 
RNA and cDNA from 10
 
5
 
 sorted
cells were prepared and amplified with gene-specific primers as
described previously (14). Primers for 
 
b
 
-actin and 
 
m
 
0
 
 have been
described (8, 14). Primers for myeloid-specific genes were as fol-
lows: lysozyme, 5
 
9
 
-CTCTGAAAAGGAATGGAATGGCTG,
3
 
9
 
-AAATCGAGGGAATGTGACCTCTCTC; c-fms, GAACGT-
GTTCATCTGTTCCCGTCC, 3
 
9
 
-TCCCCTTACCATGCCAA-
ACTGTGG.
PCR, blotting, and hybridization with gene-specific ribo-
probes were performed as described (14). 10 
 
m
 
l aliquots were
withdrawn at 18, 22, and 26 cycles (
 
b
 
-actin) or 22, 26, and 30
cycles for separate analysis to ensure that amplification was in the
linear range.
 
Single-cell PCR for Detection of D
 
H
 
J
 
H
 
 Rearrangements.
 
Detection
of D
 
H
 
J
 
H
 
 rearrangements and/or an IgH germline fragment from
individual cells was accomplished by seminested PCR as de-
scribed by Ehlich et al. (15). Cloning and nucleotide sequencing
confirmed the identity of every PCR product.
 
Intrathymic Transfer.
 
Intrathymic transfers were performed as
described by Wu et al. (6). 10
 
4
 
 sorted cells from female C57BL/6
or J
 
H
 
2
 
/
 
2
 
 (both H-2
 
b
 
 and Ly5.1
 
1
 
) mice were injected into the
 
thymus of anesthetized female B6.Ly5.2 mice given 500 rads
18–24 h previously. Enumeration and characterization of donor-
derived thymocytes were accomplished 14–28 d later by staining
recipient thymocytes with FL anti-Ly5.1 (104) and combinations
of PE or APC anti-CD3 (500-A2), PE anti-CD8 (Lyt2), and
APC anti-CD4 (GK1.5).
 
Results
 
Isolation of Early B Lineage Progenitor Cells in Adult BM.
 
We previously described a flow cytometric system for the
isolation of three early B lineage progenitor populations,
termed Frs. A
 
0
 
, A
 
1
 
, and A
 
2
 
 (8). Each population constitutes
0.1% of all cells in adult BM, bears the surface phenotype
AA4.1
 
1
 
 HSA
 
2
 
, and is further defined as B220
 
2 
 
CD4
 
low
 
(A
 
0
 
), B220
 
1 
 
CD4
 
1
 
 (A
 
1
 
), or B220
 
1 
 
CD4
 
2
 
 (A
 
2
 
) (Fig. 1 A).
Each fraction contains cells with the capacity to differenti-
ate into B220
 
1
 
 HSA
 
int
 
 pro-B cells in stromal cultures (Fig.
1 B). Interestingly, these cultures also routinely contained
CD11b
 
1 
 
B220
 
2
 
 myeloid lineage cells (not shown), suggest-
ing that these populations might also contain myeloid
progenitors. However, because these bulk cultures often
contain contaminating stem cells, we adopted a series of
quantitative culture and adoptive transfer systems in con-
junction with semiquantitative reverse transcription (RT)-
PCR and five-color flow cytometry to more precisely de-
fine the ability of these populations to give rise to cell types
other than B lymphocytes.
 
Cell Surface Phenotype of Early B Lineage Progenitor Popula-
tions.
 
Five-color FACS
 
®
 
 data for surface molecules associ-
ated with multilineage and lineage-restricted progenitor
cells are presented in Fig. 2. Bimodal expression of surface
molecules associated with multipotential progenitors such
as Sca-1/Ly6C and CD117/c-kit and the CD11b surface
antigen associated with the myeloid lineage was observed
in Fr. A
 
0
 
, implying cellular heterogeneity within this popu-
lation. In subsequent experiments, we determined that Fr.
A
 
0
 
 can be further subdivided into two discrete Sca-1
 
1
 
c-kit
 
1
 
 CD11b
 
2
 
 and Sca-1
 
2
 
 c-kit
 
2
 
 CD11b
 
1
 
 populations
(not shown).
Figure 1. Early B lineage precursor cell populations in adult BM. (A)
Four-color immunofluorescence analyses reveal the three indicated popu-
lations. (B) 104 sorted cells from Fr. A0, A1, or A2 from adult BALB/c BM
were cultured for 4 or 8 d on S17 stromal cells with 100 U/ml rIL-7, and
the number of B2201 HSAint pro-B cells was determined by flow cytom-
etry. 
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In contrast to Fr. A0, Frs. A1 and A2 each exhibited a
uniform Sca-1low c-kit2 CD11blow phenotype, whereas
B2201 CD431 HSAint pro-B cells, previously referred to as
Frs. B and C (9), were Sca-1low CD11b2 and bimodal for
c-kit. Since Rolink and colleagues have used a CD191
c-kit1 surface phenotype to define pro-B cells (16), we
were surprised to find undetectable levels of c-kit among
Frs. A1 and A2 and bimodal expression within Frs. B and C.
Although this might be attributed to differences between
particular antibodies, the c-kit antibody used (2B4) gave
brighter staining among CD191 BM cells compared with
the alternative available clone, ACK4 (data not shown).
That Frs. A1 and A2 are unique and separate B lineage
progenitor populations relative to pro-B cells defined as
CD191 c-kit1 or B220 low CD43low HSAint is also evident
from their lack of expression of CD19 (8). Frs. A0–A2 also
exhibited low to undetectable staining for IL-7Ra relative
to pro-B cells in Frs. B/C (Fig. 2). Finally, surface mole-
cules associated with lineage-restricted progenitors such as
CD3, TER-119, and Gr-1 were undetectable on all popu-
lations (data not shown).
The Extent of DHJH Recombination among Subsets of pre–
pro-B Cells. Previous experiments examining the degree
of recombination at the IgH locus in various B lineage subsets
suggest that DH-JH recombination occurs largely within the
pro-B cell compartment (9, 14, 15). However, since these
experiments were performed with a pre–pro-B cell popula-
tion subsequently shown to be heterogeneous (8, 17), we
adopted a PCR assay previously shown to detect DHJH re-
arrangements among individual cells (15) to rule out the
possibility that DH-JH rearrangement initiates in Frs. A1/A2.
Only cells with germline configuration of the IgH locus
were detected in 68 and 71 cells from Frs. A0 and A1, re-
spectively. Similarly, only 2 out of 49 cells from Fr. A2 in
which a PCR product was detected contained a D-J rear-
rangement. By comparison, 25 out of 44 pro-B cells (Fr. B)
in which a PCR product was detected displayed D-J rear-
rangements on at least 1 allele (not shown). Thus, these
data confirm previous conclusions that DHJH rearrange-
ments are initiated among pro-B cells.
Loss of Monocyte/Macrophage Progenitor Activity Occurs
before and Independently of VDJ Recombination. To examine
the myeloid lineage potential in each subset, we first used
semiquantitative RT-PCR for myeloid-specific genes. As
shown in Fig. 3 A, low level expression of c-fms was ob-
served in Frs. A0–A2 relative to the macrophage cell line
P388D1. In contrast, relatively strong expression of lyso-
zyme was observed in P388D1 and Fr. A0 but not Fr. A1 or
A2. This expression pattern was the reverse of that observed
for m0, suggesting an absence of myeloid progenitor activity
in Frs. A1 and A2.
To directly assess myeloid progenitor activity, cells from
each fraction were cultured at limiting dilution on S17
stromal cells under conditions previously shown to support
the growth of monocyte/macrophage and B lymphoid
progenitors (5). Interestingly, each fraction exhibited mark-
edly different cloning potentials under these conditions:
whereas limiting dilution was easily achieved by plating 1
cell/well for Fr. A0, 100- and 10-fold greater numbers of
cells were necessary for Frs. A1 and A2, respectively (not
shown). Regardless, 65% of wells seeded with single cells
from Fr. A0 contained both B lineage and myeloid lineage
progenitors as determined by the outgrowth of both B2201
CD11b2 HSAint and B2202 CD11b1 HSAint cells, demon-
strating the presence of bipotential myeloid/B lymphoid
progenitor cells within Fr. A0 (Fig. 3 B). In contrast, at lim-
iting dilution 100% of cultures seeded with Fr. A1 or A2
Figure 2. Surface molecule expression among defined B lineage sub-
sets. Five-color (Frs. A0–A2) or four-color (Frs. B/C) immunofluores-
cence of adult BM cells. For Frs. A0–A2, cells were stained simultaneously
with antibodies to CD4, B220, HSA, AA4.1, and the indicated surface
molecule, and expression of the indicated surface molecule on the indi-
cated population was determined as described in Materials and Methods.
For Frs. B/C, cells were stained with antibodies to CD43, HSA, B220,
and the indicated surface molecule, and expression was determined by
gating on CD43low B220low HSAint cells. BM cells were from BALB/c
mice except for Sca-1/Ly6C, for which C57BL/6 mice were used.
Figure 3. Myeloid lineage progenitor activity in Frs. A0, A1, and A2.
(A) Expression of c-fms, lysozyme, and m0 among Frs. A0, A1, and A2 was
determined by RT-PCR, and expression levels were normalized to b-actin
expression. Data are from three separate experiments. (B) Cultures estab-
lished at limiting dilution using 1, 100, and 10 cells/well for Frs. A0, A1,
and A2, respectively, were stained at day 14 for CD45R/B220 and
CD11b expression. The numbers of wells containing exclusively B2201
CD11b2 cells, B2202 CD11b1 cells, or both are shown.738 Lineage Commitment in B Lymphopoiesis
contained only B lineage B2201 CD11b2 HSAint cells, in-
dicating an absence of myeloid progenitor activity within
these populations. Likewise, when introduced into methyl-
cellulose cultures optimized for myeloid and erythroid pro-
genitors, Fr. A0 but not Fr. A1 or A2 gave rise to both mac-
rophage/granulocyte and erythroid colonies, with greater
numbers of macrophage/granulocyte colonies and fewer
erythroid colonies relative to Lin2 Sca-11 pluripotent stem
cells (Table I; reference 2). These data, together with the
stromal cell cultures described in Fig. 3 B, indicate that loss
of myeloid and erythroid precursor potential occurs before
DH-JH rearrangements. Finally, we tested whether this pro-
cess is independent of VHDHJH recombination using meth-
ylcellulose cultures initiated with cells from Rag-12/2
mice. The inability of cells within Frs. A1 and A2 to give
rise to the myeloid and erythroid lineage was unaffected by
the Rag-1 mutation, showing that loss of myeloid/eryth-
roid precursor potential occurs independent of VHDHJH re-
combination (Table I).
Loss of NK and T Lymphoid Progenitor Activity Occurs before
and Independently of VDJ Recombination. Since low surface
expression of CD4 has been associated with a thymocyte
precursor population in adult BM (18, 19) and with the
earliest T lineage precursor cell in adult thymus (6), we rea-
soned that Frs. A0 and/or A1 might also contain T lineage
progenitors. To determine T lineage progenitor activity
within Frs. A0–A2 and to test whether IgH recombination
influences B–T lymphoid lineage commitment, we per-
formed intrathymic transfers with cells from C57BL/6 or
JH
2/2 mice (both H-2b, Ly5.1) into B6.Ly5.2 recipients. As
shown in Fig. 4, Fr. A0 exhibited clear thymic precursor
activity whether taken from C57BL/6 or JH
2/2 mice. Sepa-
rate experiments demonstrated similar thymic reconstitu-
tion potentials between Fr. A0 and early thymocyte pro-T
cells (6), and thymi repopulated with Fr. A0 contained
conventional CD41CD81CD3low double positives and
CD3high single-positive thymocytes (not shown). In sharp
contrast, no T lineage progenitor activity was observed
when thymi were injected with equivalent numbers of cells
from Fr. A1 or A2, regardless of whether these populations
were taken from C57BL/6 or JH
2/2 mice (Fig. 4). More-
over, we were unable to amplify T lineage genes such as
pre-Ta and Cb using cDNA from Frs. A0–A2 (not shown).
Finally, consistent with a lack of NK cell progenitors in Frs.
A0–A2, these populations failed to proliferate in cultures
supplemented with IL-2 compared with the BM NK cell
progenitors described by Rolink et al. (17). Together, these
data indicate that pre–pro-B cells, defined as Frs. A1 and
A2, lack NK and T lymphoid as well as myeloid and eryth-
roid lineage precursor cells, demonstrating that lineage re-
striction in developing B lineage progenitors occurs before
and independently of VHDHJH recombination.
Discussion
Although previous studies have defined multipotent pro-
genitor populations in BM (2, 20–22), fetal liver (3–5, 23),
and the thymus (6), until now the lineage potential of de-
veloping B lymphocyte progenitors has not been addressed.
Here we show that the earliest B lineage progenitor popu-
lations, termed Frs. A1 and A2 and defined in part by m0 ex-
pression but lack of DH-JH rearrangements, are composed
largely if not entirely of B lineage–restricted precursors.
This conclusion is supported by their homogeneous ex-
pression of multiple cell surface molecules (Fig. 2), their
lack of expression of myeloid and T lymphoid–specific
genes (Fig. 3 A, and data not shown), their inability to give
rise to myeloid, erythroid, and non-B lymphoid lineage
cells (Figs. 3 and 4), and their near 100% expression of an
IgH transgene (8). Finally, we show that mechanisms con-
trolling B lineage restriction do not require VHDHJH rear-
rangements, since commitment was unaffected in early B
lineage progenitors taken from mice incapable of initiating
this process.
Significantly, although others have shown that pro-B
cells incapable of VHDHJH recombination can be driven to
mature in vitro (24), such experiments did not test whether
pro-B cells can give rise to alternative lineages or whether
IgH rearrangements play a role in this process. Similarly, al-
though mutations in transcription factors such as E12/E47
that result in impairment of DH-JH rearrangements have
Table I. Capacity of Defined Precursor Populations from C57BL/6 
and Rag-12/2 Mice to Differentiate into Myeloid and Erythroid 
Lineage Cells
Mouse Cells cultured CFU-GM CFU-BFE CFU-GEMM
C57BL/6 Stem 26.4 (5.0) 6.80 (1.2) 8.20 (1.5)
A0 14.2 (1.4) 1.70 (0.5) 0.68 (0.15)
A1 00 0
A2 00 0
Rag-12/2 A0 15.1 (1.17) 1.58 (0.15) 0.89 (0.51)
A1 00 0
A2 00 0
2,000 (stem, Lin2 Sca-11) or 4,000 (Frs. A0–A2) sorted cells were cul-
tured in methylcellulose medium optimized for myeloid and erythroid
cell types. After 12 d, cultures were scored for the number of granu-
locytic/macrophage (CFU-GM), erythroid (CFU-BFE), and mixed
(CFU-GEMM) colonies. Means for triplicate cultures are shown with
SDs in parentheses. Data are normalized for 1,000 input cells/culture.
Figure 4. T lymphocyte pro-
genitor activity in Frs. A0, A1,
and A2 from C57BL/6 or JH
2/2
mice. Intrathymic transfers of the
indicated BM fraction 19 d after
transfer. 104 sorted cells from
C57BL/6 (open symbols) or JH
2/2
(filled symbols) (both Ly5.11)
mice were transferred into each
irradiated B6.Ly5.2 recipient,
and the number of Ly5.11 thy-
mocytes was determined.739 Allman et al. Brief Definitive Report
been said to affect B lineage commitment per se (25),
whether these mutations affect B lineage commitment ver-
sus differentiation or survival of early B lineage progenitors
remains to be determined. However, our data do not ex-
clude a connection between mechanisms controlling B lin-
eage commitment and other events associated with very
early B lymphopoiesis such as alteration of chromatin struc-
ture at the IgH locus and initiation of m0 expression.
The definition of B lineage progenitor populations lack-
ing both DH-JH rearrangements and myeloid lineage po-
tential also has implications for the origins of natural and
induced myelogenous leukemias containing IgH rearrange-
ments (10–13). While one interpretation of these observa-
tions was that these cells arose from bipotential myeloid/B
lymphoid precursors after DH-JH rearrangement, an alterna-
tive explanation supported by our data is that such cells are
the result of oncogene-induced lineage instability among
pro-B cells. Similarly, cells within Fr. A1 share many char-
acteristics with a novel lymphoid tumor derived from Em-
myc 3 Em–bcl-2 transgenic mice (26). These tumor cells,
like Fr. A1, are B2201 CD41 HSA2, and express m0 but
lack IgH rearrangements. However, unlike Fr. A1, these
tumors exhibit myeloid and B lymphoid progenitor activ-
ity. These observations, together with our data, suggest that
coordinated expression of myc and bcl-2 within Fr. A1 dis-
rupts lineage commitment in otherwise lineage-restricted
pre–pro-B cells.
In conclusion, the differentiation of pluripotent stem cells
into lineage-restricted progenitors for each hematopoietic
lineage is a complex and highly controlled process. This
complexity is reflected in part by the presence of multiple
discrete cell populations with varying levels of multilineage
progenitor activity, the existence of key transcriptional reg-
ulatory proteins such as Pax-5/BSAP, EBF, E12/47, and
Ikaros, important for the differentiation or survival of
unique progenitor populations (27), and potential differ-
ences in soluble factors important for multilineage and lin-
eage-restricted cells (28). A reassessment of those studies vis
a vis the data presented here, together with a description of
the developmental relationship between pre–pro-B cells
and the recently described common lymphoid progenitor
population in adult BM (7), should eventually yield an un-
derstanding of the cellular and molecular interactions re-
sponsible for B lineage commitment.
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